BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 17426224)

  • 1. Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease.
    Thomson RM; Armstrong JG; Looke DF
    Chest; 2007 Apr; 131(4):1166-72. PubMed ID: 17426224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ; Wu TS; Chiang PC; Lee MH
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of the recommendations of the conference of consensus in front of symptoms ENT, respiratory or thoracic pains considered as due to a gastroesophageal reflux disease].
    Vallot T; Ducrotte P; Bour B; Jacques JP; Houcke P; De Korwin JD; Pariente A; Aygalenq P; Coudsy B; Carrois F; Ricci L; Bruley des Varannes S
    Presse Med; 2013 May; 42(5):e125-32. PubMed ID: 23414966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy.
    Koyama K; Ohshima N; Kawashima M; Okuda K; Sato R; Nagai H; Matsui H; Ohta K
    Respir Med; 2015 Oct; 109(10):1347-53. PubMed ID: 26365483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].
    Ogawa K; Sano C
    Kekkaku; 2013 Mar; 88(3):355-71. PubMed ID: 23672176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of gastroesophageal reflux disease.
    Pettit M
    Pharm World Sci; 2005 Dec; 27(6):432-5. PubMed ID: 16341949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing patients with pulmonary Mycobacterium avium complex disease and associated underlying diseases in Japan.
    Ito Y; Hirai T; Fujita K; Maekawa K; Niimi A; Ichiyama S; Mishima M
    J Infect Chemother; 2015 May; 21(5):352-6. PubMed ID: 25640532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease.
    Tanaka E; Amitani R; Niimi A; Suzuki K; Murayama T; Kuze F
    Am J Respir Crit Care Med; 1997 Jun; 155(6):2041-6. PubMed ID: 9196113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: treatment of gastroesophageal reflux disease in the elderly.
    Poh CH; Navarro-Rodriguez T; Fass R
    Am J Med; 2010 Jun; 123(6):496-501. PubMed ID: 20569750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease.
    Maugein J; Dailloux M; Carbonnelle B; Vincent V; Grosset J;
    Eur Respir J; 2005 Dec; 26(6):1092-6. PubMed ID: 16319341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease.
    Koh WJ; Lee JH; Kwon YS; Lee KS; Suh GY; Chung MP; Kim H; Kwon OJ
    Chest; 2007 Jun; 131(6):1825-30. PubMed ID: 17400680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and pharmacological treatment of gastroesophageal reflux disease.
    Storr M; Meining A; Allescher HD
    Dig Dis; 2000; 18(2):93-102. PubMed ID: 11060472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid suppression therapy: where do we go from here?
    Scarpignato C; Pelosini I; Di Mario F
    Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by Mycobacterium avium-intracellulare complex (MAC) infection.
    Sugihara E; Hirota N; Niizeki T; Tanaka R; Nagafuchi M; Koyanagi T; Ono N; Rikimaru T; Aizawa H
    J Infect Chemother; 2003 Dec; 9(4):328-32. PubMed ID: 14691654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of gastroesophageal reflux symptoms in exacerbations of COPD.
    Rascon-Aguilar IE; Pamer M; Wludyka P; Cury J; Coultas D; Lambiase LR; Nahman NS; Vega KJ
    Chest; 2006 Oct; 130(4):1096-101. PubMed ID: 17035443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):628-34. PubMed ID: 12102303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ
    J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease.
    Ruigómez A; Hungin AP; Lundborg P; Johansson S; Wallander MA; García Rodríguez LA
    Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):232-7. PubMed ID: 21258240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
    Gerson LB; Robbins AS; Garber A; Hornberger J; Triadafilopoulos G
    Am J Gastroenterol; 2000 Feb; 95(2):395-407. PubMed ID: 10685741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.